Wanbangde Pharmaceutical Holding Group Co Ltd Net Asset Quality Index
Wanbangde Pharmaceutical Holding Group Co Ltd net asset quality index. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Net Asset Quality Index of 59.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.55 Billion minus total liabilities of CN¥1.86 Billion yields net assets of CN¥2.70 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Wanbangde Pharmaceutical Holding Group C to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Net asset quality index of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. This chart shows how Wanbangde Pharmaceutical Holding Group Co Ltd's Net Asset Quality Index has evolved across 23 annual periods from 2003 to 2025. As of March 2026, the index stands at 59.2%, representing net assets of CN¥2.70 Billion against total assets of CN¥4.55 Billion CNY. See what is Wanbangde Pharmaceutical Holding Group C's book value for net asset value and shareholders' equity analysis.
Wanbangde Pharmaceutical Holding Group Co Ltd Net Asset Quality Index by Year (2003–2025)
Wanbangde Pharmaceutical Holding Group Co Ltd net asset quality index by year from 2003 to 2025. The table below presents the year-by-year Net Asset Quality Index for Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Wanbangde Pharmaceutical Holding Group C.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 59.4% | CN¥2.61 Billion | CN¥4.39 Billion | CN¥1.78 Billion | ▼ -4.3 pp |
| 2024 | 63.7% | CN¥2.76 Billion | CN¥4.33 Billion | CN¥1.57 Billion | ▼ -0.5 pp |
| 2023 | 64.2% | CN¥2.76 Billion | CN¥4.30 Billion | CN¥1.54 Billion | ▼ -2.7 pp |
| 2022 | 66.9% | CN¥2.82 Billion | CN¥4.22 Billion | CN¥1.40 Billion | ▲ +4.1 pp |
| 2021 | 62.8% | CN¥2.74 Billion | CN¥4.37 Billion | CN¥1.63 Billion | ▲ +12.3 pp |
| 2020 | 50.5% | CN¥2.86 Billion | CN¥5.66 Billion | CN¥2.80 Billion | ▲ +0.2 pp |
| 2019 | 50.3% | CN¥1.91 Billion | CN¥3.80 Billion | CN¥1.89 Billion | ▼ -10.3 pp |
| 2018 | 60.6% | CN¥1.72 Billion | CN¥2.85 Billion | CN¥1.12 Billion | ▼ -15.8 pp |
| 2017 | 76.4% | CN¥1.60 Billion | CN¥2.10 Billion | CN¥496.58 Million | ▼ -7.9 pp |
| 2016 | 84.2% | CN¥1.40 Billion | CN¥1.66 Billion | CN¥261.85 Million | ▲ +0.9 pp |
| 2015 | 83.3% | CN¥1.35 Billion | CN¥1.62 Billion | CN¥270.28 Million | ▼ -0.3 pp |
| 2014 | 83.6% | CN¥1.30 Billion | CN¥1.55 Billion | CN¥254.69 Million | ▲ +6.9 pp |
| 2013 | 76.7% | CN¥1.19 Billion | CN¥1.55 Billion | CN¥361.07 Million | ▲ +6.6 pp |
| 2012 | 70.1% | CN¥1.10 Billion | CN¥1.57 Billion | CN¥469.09 Million | ▼ -2.8 pp |
| 2011 | 72.9% | CN¥1.05 Billion | CN¥1.45 Billion | CN¥392.22 Million | ▲ +1.8 pp |
| 2010 | 71.1% | CN¥936.13 Million | CN¥1.32 Billion | CN¥380.46 Million | ▼ -1.4 pp |
| 2009 | 72.5% | CN¥811.59 Million | CN¥1.12 Billion | CN¥307.39 Million | ▲ +2.8 pp |
| 2008 | 69.7% | CN¥712.31 Million | CN¥1.02 Billion | CN¥309.46 Million | ▲ +25.0 pp |
| 2007 | 44.8% | CN¥415.12 Million | CN¥927.63 Million | CN¥512.51 Million | ▲ +2.7 pp |
| 2006 | 42.0% | CN¥357.72 Million | CN¥851.57 Million | CN¥493.85 Million | ▲ +18.9 pp |
| 2005 | 23.1% | CN¥152.88 Million | CN¥661.73 Million | CN¥508.84 Million | ▼ -9.6 pp |
| 2004 | 32.7% | CN¥136.17 Million | CN¥416.66 Million | CN¥280.48 Million | ▼ -5.0 pp |
| 2003 | 37.7% | CN¥98.53 Million | CN¥261.57 Million | CN¥163.05 Million | — |